NanoString

NanoString

NanoString

Provider of life science tools for translational research based on the nCounter® technology for single-molecule counting.
Founded
2003
Raised
$160M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$56,000,000
Post-IPO equity - 2017
Team Size
1–10
Employees
$56,000,000 Post-IPO equity
bizjournals

NanoString raises $56 million through common stock offering

GeekWire

Biotechnology company NanoString partners with Merck to create test for anti-cancer drug

Health Earnings